May 11, 2021 4:10 pm EDT VolitionRx Limited Announces First Quarter 2021 Financial Results and Business Update
May 6, 2021 8:15 am EDT VolitionRx Limited Schedules First Quarter 2021 Earnings Conference Call and Business Update
Mar 31, 2021 8:30 am EDT VolitionRx Limited Announces Publication of Significant Nu.Q® Capture Mass Spectrometry Paper
Mar 30, 2021 8:30 am EDT VolitionRx Limited Appoints Dr. Tom Butera DVM as Chief Executive Officer for Volition Veterinary Subsidiary
Mar 22, 2021 4:10 pm EDT VolitionRx Limited Announces Full Fiscal Year 2020 Financial Results and Business Update
Mar 16, 2021 8:30 am EDT VolitionRx Limited Schedules Full Fiscal Year 2020 Earnings Conference Call and Business Update
Feb 12, 2021 9:25 am EST VolitionRx Limited Announces Closing of $20 Million Underwritten Public Offering of Common Stock
